DHR
Danaher Corporation
NYSE · Healthcare · Medical - Diagnostics & Research · US
$207.27
−1.78%Forward multiples
Based on analyst estimates
- P/E forward
- 23.44x
- P/E 2026E
- 24.60x
- P/E 2027E
- 22.53x
- P/E 2028E
- 20.51x
- P/S forward
- 5.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- 36.68x
- PEG TTM
- 0.66x
- Price / book
- 2.77x
- Price / sales
- 5.80x
- Price / cash flow
- 21.96x
Enterprise value
- Enterprise value
- $167.9B
- EV / sales
- 6.69x
- EV / EBITDA
- 23.48x
- EV / EBIT
- 32.75x
- Market cap
- $145.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026